Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
Despite the incidence and prevalence of urothelial bladder cancer (UBC), few advances in treatment and diagnosis have been made in recent years. In this review, we discuss potential biomarker candidates: the tropomyosin family of genes, encoded by four loci in the human genome. The expression of the...
Main Authors: | Nada Humayun-Zakaria, Roland Arnold, Anshita Goel, Douglas Ward, Stuart Savill, Richard T. Bryan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/20/5/1102 |
Similar Items
-
Sex-related differences in urothelial cell carcinoma of the bladder in Germany
by: Scheller T, et al.
Published: (2018-12-01) -
THE FUNCTIONAL SIGNIFICANCE OF THE STRIATED ISOFORM OF TROPOMYOSIN 3 IN NORMAL AND PATHOLOGICAL STATES
by: Pieples, Kathy
Published: (2001) -
Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
by: Itamar Getzler, et al.
Published: (2018-10-01) -
α‐tropomyosin gene (TPM3) mutation in an infant with nemaline myopathy
by: Sulaiman Almobarak, et al.
Published: (2021-03-01) -
l-Carnitine ameliorates congenital myopathy in a tropomyosin 3 de novo mutation transgenic zebrafish
by: Po-Jui Hsu, et al.
Published: (2021-01-01)